Andreas Koblet

Discovery of the imidazo[1,5-a][1,2,4]-triazolo[1,5-d][1,4]benzodiazepine scaffold as a novel, potent and selective GABA(A) alpha5 inverse agonist series.

F. Blasco, F. Knoflach, G. Trube, 2009, Bioorganic & medicinal chemistry letters.

Identification of Three Novel Radiotracers for Imaging Aggregated Tau in Alzheimer's Disease with Positron Emission Tomography.

M. Körner, D. Holt, T. Hartung, 2017, Journal of medicinal chemistry.

The discovery and unique pharmacological profile of RO4938581 and RO4882224 as potent and selective GABAA alpha5 inverse agonists for the treatment of cognitive dysfunction.

F. Knoflach, G. Trube, H. Fischer, 2009, Bioorganic & medicinal chemistry letters.

Discovery of potent, balanced and orally active dual NK1/NK3 receptor ligands.

W. Spooren, J. Peters, T. Hoffmann, 2010, Bioorganic & medicinal chemistry letters.

Discovery of the imidazo[1,5-a][1,2,4]-triazolo[1,5-d][1,4]benzodiazepine scaffold as a novel, potent and selective GABA(A) alpha5 inverse agonist series.

F. Blasco, F. Knoflach, G. Trube, 2009, Bioorganic & Medicinal Chemistry Letters.